North China Pharmaceutical is a finished-dose manufacturer based in China. It appears in 236 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with INHRR (VE), MINSA (CR) and EFDA (ET). Its GMP standing is certified by MFDS (Korea), ANVISA (Brazil) and INVIMA (CO).
| Site | FDA FEI |
|---|---|
| HEBEI, China | Not on file |
| China, China | 3038207912 |
| Shijiazhuang, Colombia | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| INHRR (VE) | 151 | None |
| MINSA (CR) | 26 | None |
| EFDA (ET) | 15 | None |
| ARCSA (EC) | 14 | None |
| NAFDAC (NG) | 10 | None |
| ZAMRA (ZM) | 10 | None |
| MFDS (Korea) | None | 2 |
| ANVISA (Brazil) | None | 1 |
| INVIMA (CO) | None | 1 |
Choose your molecules and target markets. North China Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free